Haloni Jane Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Haloni Jane Tbk. trades at Rp74 (market cap 443.75B, 14.79M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Haloni Jane Tbk. is far larger — about 4.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| HALO | SCPI | |
|---|---|---|
Market Cap | 443.75B | 104.4B |
Volume | 14.79M | — |
Lot | 147.92K | — |
Turnover | 1.1B | — |
Average Price | 74.32 | — |
Value | 1.1B | — |
Indicative Equilibrium Price | 74 | — |
Indicative Equilibrium Volume | 1.08K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Haloni Jane Tbk (the "Company") domiciled in Tangerang, Indonesia, was established based onthe Notarial Deed No. 2 dated November 07, 2001 by Notary Harsono, S,H., In Tangerang. The Company is controlled by Mr. Hansen Jap.
Read more on HALO →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →